Novo Nordisk is a global healthcare company specializing in diabetes care, hemophilia, growth hormone therapy, and hormone replacement therapy. The company has a strong presence in the diabetes care market, driven by its innovative insulin products and extensive research and development capabilities. Novo Nordisk's commitment to sustainability and corporate social responsibility has further bolstered its brand reputation. However, the company faces challenges such as regulatory hurdles, pricing pressures, and competition from other pharmaceutical companies. As the healthcare landscape evolves, Novo Nordisk has opportunities to expand its product portfolio, enter new markets, and leverage digital health technologies to enhance patient care.